UZH-Logo

Maintenance Infos

N-terminal pro-B-type natriuretic peptide ratio predicts mortality after transcatheter aortic valve replacement


Stähli, Barbara E; Gebhard, Cathérine; Saleh, Lanja; Falk, Volkmar; Landmesser, Ulf; Nietlispach, Fabian; Maisano, Francesco; Lüscher, Thomas F; Maier, Willibald; Binder, Ronald K (2015). N-terminal pro-B-type natriuretic peptide ratio predicts mortality after transcatheter aortic valve replacement. Catheterization and Cardiovascular Interventions, 85(7):1240-1247.

Abstract

Objectives: We studied the prognostic value of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP)-ratio, which is independent of individual cut-off levels, in predicting mortality in patients undergoing transcatheter aortic valve replacement (TAVR). Background: Elevated levels of natriuretic peptides are associated with adverse outcomes across a wide spectrum of cardiovascular diseases. However, cut-off values differ according to age, gender, and body weight. Methods: 244 TAVR patients with pre-procedural NT-proBNP levels were analyzed, and the predictive value of NT-proBNP-ratio (measured NT-proBNP/maximal normal NT-proBNP values specific for age and gender) on all-cause-mortality was assessed in a multivariate model. Results: Median BNP-ratio was 4.2 [IQR 1.8-9.7]. All-cause mortality at 30 days was 3.4% in patients with less than median NT-proBNP-ratio, and 14.0% in patients with more than median NT-proBNP-ratio (p=0.02). All-cause mortality at 1 year was 8.5% in patients with less than median NT-proBNP-ratio, and 32.1% in those with more than median NT-proBNP-ratio (p=0.001). Cumulative survival declined with increasing quartiles of NT-proBNP-ratio (log rank p=0.001). All patients with a NT-proBNP-ratio below 1.5 survived at 1 year follow-up. In ROC analysis, NT-proBNP-ratio significantly predicted 30-day (AUC=0.72; p=0.002) and 1-year all-cause mortality (AUC=0.72; p<0.001). By multivariate Cox regression analysis, NT-proBNP-ratio, chronic obstructive pulmonary disease, and serum creatinine were the only independent predictors of all-cause mortality. Conclusions: Elevated NT-proBNP-ratio was associated with increased short- and long-term mortality after TAVR, and independently predicted all-cause mortality. NT-proBNP-ratio should be considered in the risk stratification of patients undergoing TAVR. This article is protected by copyright. All rights reserved.

Objectives: We studied the prognostic value of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP)-ratio, which is independent of individual cut-off levels, in predicting mortality in patients undergoing transcatheter aortic valve replacement (TAVR). Background: Elevated levels of natriuretic peptides are associated with adverse outcomes across a wide spectrum of cardiovascular diseases. However, cut-off values differ according to age, gender, and body weight. Methods: 244 TAVR patients with pre-procedural NT-proBNP levels were analyzed, and the predictive value of NT-proBNP-ratio (measured NT-proBNP/maximal normal NT-proBNP values specific for age and gender) on all-cause-mortality was assessed in a multivariate model. Results: Median BNP-ratio was 4.2 [IQR 1.8-9.7]. All-cause mortality at 30 days was 3.4% in patients with less than median NT-proBNP-ratio, and 14.0% in patients with more than median NT-proBNP-ratio (p=0.02). All-cause mortality at 1 year was 8.5% in patients with less than median NT-proBNP-ratio, and 32.1% in those with more than median NT-proBNP-ratio (p=0.001). Cumulative survival declined with increasing quartiles of NT-proBNP-ratio (log rank p=0.001). All patients with a NT-proBNP-ratio below 1.5 survived at 1 year follow-up. In ROC analysis, NT-proBNP-ratio significantly predicted 30-day (AUC=0.72; p=0.002) and 1-year all-cause mortality (AUC=0.72; p<0.001). By multivariate Cox regression analysis, NT-proBNP-ratio, chronic obstructive pulmonary disease, and serum creatinine were the only independent predictors of all-cause mortality. Conclusions: Elevated NT-proBNP-ratio was associated with increased short- and long-term mortality after TAVR, and independently predicted all-cause mortality. NT-proBNP-ratio should be considered in the risk stratification of patients undergoing TAVR. This article is protected by copyright. All rights reserved.

Citations

3 citations in Web of Science®
2 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiovascular Surgery
04 Faculty of Medicine > University Hospital Zurich > Institute of Clinical Chemistry
04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:610 Medicine & health
540 Chemistry
Language:English
Date:2015
Deposited On:14 Jan 2015 08:27
Last Modified:05 Apr 2016 18:45
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:1522-1946
Publisher DOI:https://doi.org/10.1002/ccd.25788
PubMed ID:25511571

Download

Full text not available from this repository.View at publisher

TrendTerms

TrendTerms displays relevant terms of the abstract of this publication and related documents on a map. The terms and their relations were extracted from ZORA using word statistics. Their timelines are taken from ZORA as well. The bubble size of a term is proportional to the number of documents where the term occurs. Red, orange, yellow and green colors are used for terms that occur in the current document; red indicates high interlinkedness of a term with other terms, orange, yellow and green decreasing interlinkedness. Blue is used for terms that have a relation with the terms in this document, but occur in other documents.
You can navigate and zoom the map. Mouse-hovering a term displays its timeline, clicking it yields the associated documents.

Author Collaborations